TITLE

Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): a pragmatic randomised trial

AUTHOR(S)
Beretta, Simone; Beghi, Ettore; Messina, Paolo; Gerardi, Francesca; Pescini, Francesca; La Licata, Andrea; Specchio, Luigi; Ferrara, Mariangela; Canevini, Maria Paola; Turner, Katherine; La Briola, Francesca; Franceschetti, Silvana; Binelli, Simona; Giglioli, Isabella; Galimberti, Carlo Andrea; Fattore, Cinzia; Zaccara, Gaetano; Tramacere, Luciana; Sasanelli, Francesco; Pirovano, Marta
PUB. DATE
August 2014
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Aug2014, Vol. 85 Issue 8, p887
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The impact of educational strategies in the management of adverse treatment effects and drug interactions in adult patients with epilepsy with comorbidities remains undetermined. Background: The impact of educational strategies in the management of adverse treatment effects and drug interactions in adult patients with epilepsy with comorbidities remains undetermined. Methods: 174 adult patients with epilepsy with chronic comorbidities, multiple-drug therapy and reporting at least one adverse treatment effect and/or drug interaction at study entry were randomly assigned to the educational plan or usual care. The primary endpoint was the number of patients becoming free from adverse treatment events and/or drug interactions after a 6- month follow-up. The number of adverse treatment events and drug interactions, health-related quality of life (HRQOL) summary score changes and the monetary costs of medical contacts and drugs were assessed as secondary outcomes. Results: The primary endpoint was met by 44.0% of patients receiving the educational plan versus 28.9% of those on usual care (p=0.0399). The control group reported a significantly higher risk not to meet successfully the primary endpoint at the end of the study: OR (95% CI) of 2.29 (1.03 to 5.09). A separate analysis on drug adverse effects and drug interactions showed that the latter were more sensitive to the effect of educational treatment. Quality of life and costs were not significantly different in the two groups. Conclusions A patient-tailored educational strategy is effective in reducing drug-related problems (particularly drug interactions) in epilepsy patients with chronic comorbidities, without adding significant monetary costs.
ACCESSION #
99136571

 

Related Articles

  • Adherence to Treatment and Factors Affecting Adherence of Epileptic Patients at Yirgalem General Hospital, Southern Ethiopia: A Prospective Cross-Sectional Study. Hasiso, Temesgen Yohannes; Desse, Tigestu Alemu // PLoS ONE;9/29/2016, Vol. 11 Issue 9, p1 

    Background: Non adherence of epileptic patients to antiepileptic medication often leads to an increased risk of seizures and worsening of disease, death and increased health care costs. Objective: to assess adherence to treatment and factors affecting adherence of epileptic patients at...

  • Refractory gout brings economic pain.  // PharmacoEconomics & Outcomes News;3/5/2011, Issue 623, p5 

    The article discusses the study "Comorbidity Burden, Healthcare Resource Utilization and Costs in Chronic Gout Patients Refractory to Conventional Urate-Lowering Therapy," by E. Q. Wu et al, which found the link between economic burden and refractory gout.

  • Epidemiology of benign paroxysmal positional vertigo: a population based study. von Brevern, M.; Radtke, A.; Lezius, F.; Feldmann, M.; Ziese, T.; Lempert, T.; Neuhauser, H. // Journal of Neurology, Neurosurgery & Psychiatry;Jul2007, Vol. 78 Issue 7, p710 

    Objectives: To examine the prevalence and incidence, clinical presentation, societal impact and comorbid conditions of benign paroxysmal positional vertigo (BPPV) in the general population. Methods: Cross-sectional, nationally representative neurotological survey of the general adult population...

  • The importance of comorbidity in analysing patient costs in Swedish primary care. Engström, Sven G.; Carlsson, Lennart; Östgren, Carl-Johan; Nilsson, Gunnar H.; Borgquist, Lars A. // BMC Public Health;2006, Vol. 6 Issue 1, p36 

    Background: The objective was to explore the usefulness of the morbidity risk adjustment system Adjusted Clinical Groups® (ACG), in comparison with age and gender, in explaining and estimating patient costs on an individual level in Swedish primary health care. Data were retrieved from two...

  • Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland. Huber, Carola A.; Diem, Peter; Schwenkglenks, Matthias; Rapold, Roland; Reich, Oliver // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;2014, Vol. 7, p455 

    Background: Estimating the prevalence of comorbidities and their associated costs in patients with diabetes is fundamental to optimizing health care management. This study assesses the prevalence and health care costs of comorbid conditions among patients with diabetes compared with patients...

  • Supporting Patient Safety for Seniors Through Integrated Data Systems. Streator, Scott; Stettin, Glen D. // Benefits & Compensation Digest;Feb2006, Vol. 43 Issue 2, p22 

    The article presents information on an integrated data system implemented by the members of the Ohio Public employees retirement system in February 2006. The technology protects patients from all-too-common health threats such as drug related diseases and drug-to-drug interactions. The...

  • 2010 Guide to Psychiatric Drug Interactions. Preskorn, Sheldon H.; Flockhart, David // Primary Psychiatry;Dec2009, Vol. 16 Issue 12, p45 

    Drug-drug interactions (DDIs) are a concern for the prescriber because they have the potential for causing untoward outcomes for everyone involved: morbidity for the patient, liability for the prescriber, and increased costs for the healthcare system. The risk of unintended and untoward DDIs is...

  • Confessions of a counter-detailer, part 3: Patient/prescriber advocate. Greg, Mark E. // Drug Topics;Mar2012, Vol. 156 Issue 3, p19 

    In this article the author discusses the low costs of generic drugs. According to the author, physicians and pharmacists prescribe medications because they become familiar with them and know what to expect in terms of patient response, side effects, and drug interactions. The author says that...

  • Medication errors top patient worries.  // Long Island Business News (7/1993 to 5/2009);11/05/99, Vol. 46 Issue 45, p3B 

    Lists the 10 most common worries of patients in the United States, according to an American Society of Health-System Pharmacists survey. Includes getting the wrong medication; Negative drug interactions; Cost of treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics